We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSTRU
626
DELISTED
Oyster Enterprises Acquisition Corp. Unit
OSTRU
$3.01M 0.01%
302,300
CPARU
627
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
$3M 0.01%
300,000
ASZ.U
628
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
$3M 0.01%
300,000
NPTN
629
DELISTED
NEOPHOTONICS CORP
NPTN
$3M 0.01%
+195,000
New +$2.57M
ANZUU
630
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
$2.99M 0.01%
300,000
USCTU
631
DELISTED
Roth CH Acquisition Co. Unit
USCTU
$2.98M 0.01%
+300,000
New +$3.03M
EQHA.U
632
DELISTED
EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
EQHA.U
$2.98M 0.01%
300,700
AKLI
633
DELISTED
Akili Inc
AKLI
$2.98M 0.01%
300,000
OHPAU
634
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$2.98M 0.01%
300,000
BRO icon
635
Brown & Brown
BRO
$24.6B
$2.97M 0.01%
42,321
+5,068
+14% +$327K
PROK icon
636
ProKidney
PROK
$316M
$2.97M 0.01%
300,000
DNAB
637
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$2.97M 0.01%
300,000
DNAD
638
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.95M 0.01%
300,000
SMIHU
639
DELISTED
Summit Healthcare Acquisition Corp. Units
SMIHU
$2.92M 0.01%
292,080
CNDA.U
640
DELISTED
Concord Acquisition Corp II Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
CNDA.U
$2.85M 0.01%
276,950
CPAAU
641
DELISTED
Conyers Park III Acquisition Corp. Unit
CPAAU
$2.83M 0.01%
280,268
TEAM icon
642
Atlassian
TEAM
$25.4B
$2.78M 0.01%
7,300
SI
643
DELISTED
Silvergate Capital Corporation
SI
$2.77M 0.01%
18,666
+12,944
+226% +$2.21M
CROX icon
644
Crocs
CROX
$6.75B
$2.77M 0.01%
21,570
-11,164
-34% -$1.72M
GXO icon
645
GXO Logistics
GXO
$6.13B
$2.76M 0.01%
30,435
+5,708
+23% +$513K
ACMR icon
646
ACM Research
ACMR
$4.98B
$2.75M 0.01%
96,726
-11,760
-11% -$372K
DHBCU
647
DELISTED
DHB Capital Corp. Unit
DHBCU
$2.72M 0.01%
275,000
ROCGU
648
DELISTED
Roth CH Acquisition IV Co. Unit
ROCGU
$2.68M 0.01%
250,000
RDNW
649
RideNow Group
RDNW
$251M
$2.67M 0.01%
64,251
+44,018
+218% +$1.75M
RBC icon
650
RBC Bearings
RBC
$18.2B
$2.62M 0.01%
12,958
-1,517
-10% -$326K

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.